Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 19/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 11/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL4997811 | 0.80 | LTA4H (0.54) | LTA4HKCNH2EPHX2CYP1A2CYP3A4 | |
| SCHEMBL2170482 | 0.79 | LTA4H (0.59) | LTA4HKCNH2EPHX2CYP1A2CYP3A4 | |
| SCHEMBL22224238 | 0.79 | LTA4H (0.56) | LTA4HKCNH2EPHX2CYP1A2CYP3A4 | |
| SCHEMBL4967382 | 0.78 | LTA4H (0.55) | LTA4HKCNH2EPHX2CYP1A2CYP3A4 | |
| SCHEMBL5001617 | 0.78 | LTA4H (0.43) | LTA4HKCNH2 | |
| SCHEMBL4998292 | 0.78 | LTA4H (0.42) | LTA4HKCNH2SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL4693394 | 0.78 | LTA4H (0.53) | LTA4HKCNH2EPHX2 | |
| SCHEMBL6407613 | 0.77 | LTA4H (0.52) | LTA4HKCNH2EPHX2CYP1A2CYP3A4 | |
| SCHEMBL2168329 | 0.77 | LTA4H (0.58) | LTA4HKCNH2EPHX2CYP1A2CYP3A4 | |
| SCHEMBL22224212 | 0.76 | LTA4H (0.58) | LTA4HKCNH2EPHX2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1660492-B1 | BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2008-08-20 | — | — | EP | claimed |